CLINUVEL Adds ACTH to Portfolio
Melbourne, Australia, 08 November 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read More
CLINUVEL Investor Webinar Released
CLINUVEL PHARMACEUTICALS LTD today announced an Investor Webinar shall be held on...
Read More
First Patient Treated in CLINUVEL DNA Repair Study
Melbourne, Australia, 22 October 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read More
CLINUVEL Investor webinar
CLINUVEL PHARMACEUTICALS LTD today announced an Investor Webinar shall be held on...
Read More
Appendix 4G & Corporate Governance Statement
Melbourne, Australia, 08 October 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read More
CLINUVEL PHARMACEUTICALS LTD 2021 Annual General Meeting - Notice of Meeting & Explanatory Memorandum
Melbourne, Australia, 08 October 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read More
Operations Update II
Melbourne, Australia, 07 October 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read More
Operations Update Webcast II
Melbourne, Australia, 07 October 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read More
CLINUVEL Progresses DNA Repair Program
Melbourne, Australia, 05 October 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read More
CLINUVEL Key Events and Announcements
Melbourne, Australia, 23 September 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read More
CLINUVEL Confirms AGM Date
Melbourne, Australia, 22 September 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read More
Presentation H.C. Wainwright Global Investment Conference
Melbourne, Australia, 14 September 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read More
CLINUVEL Kommuniqué IV
Sehr geehrte Aktionärinnen und Aktionäre, liebe Freunde, Einleitung Zufrieden blicken wir auf...
Read More
CLINUVEL Investor Webinar Financial Results Year Ended 30 June 2021
Melbourne, Australia, 27 August 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read More
CLINUVEL Communiqué IV
Dear Shareholders, Friends Introduction With satisfaction, we look back at an eventful...
Read More